Cargando…

Cervical cancer screening programmes and policies in 18 European countries

A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Cancer Screening Network, and the International Agency for Research on Cancer, IARC, between August and December 2003 in 35 centres in 20 European countries with reliable cervical cancer incidence and/or...

Descripción completa

Detalles Bibliográficos
Autores principales: Anttila, A, Ronco, G, Clifford, G, Bray, F, Hakama, M, Arbyn, M, Weiderpass, E
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409887/
https://www.ncbi.nlm.nih.gov/pubmed/15280916
http://dx.doi.org/10.1038/sj.bjc.6602069
_version_ 1782155890252578816
author Anttila, A
Ronco, G
Clifford, G
Bray, F
Hakama, M
Arbyn, M
Weiderpass, E
author_facet Anttila, A
Ronco, G
Clifford, G
Bray, F
Hakama, M
Arbyn, M
Weiderpass, E
author_sort Anttila, A
collection PubMed
description A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Cancer Screening Network, and the International Agency for Research on Cancer, IARC, between August and December 2003 in 35 centres in 20 European countries with reliable cervical cancer incidence and/or mortality data in databanks held at IARC and WHO. The questionnaire was completed by 28 centres from 20 countries. The final tables included information on 25 centres from 18 countries. Six countries had started screening in the 1960s, whereas 10 countries or regions had started at least a pilot programme by 2003. There were six invitational and nine partially invitational programmes, the rest employing opportunistic screening only. Recommended lifetime number of smears varied from seven to more than 50. Coverage of smear test within the recommended screening interval (usually 3 or 5 years) was above 80% in three countries. Screening registration took place in 13 programmes. Eight programmes reported the rates of screen-detected cervical cancers and precursor lesions. There was wide variation in the CIN3 detection rates. International guidelines and quality assurance protocols are useful for monitoring and evaluating screening programmes systematically. Our survey indicated that the recommendations as currently given are met in only few European countries. Health authorities need to consider stronger measures and incentives than those laid out in the current set of recommendations.
format Text
id pubmed-2409887
institution National Center for Biotechnology Information
language English
publishDate 2004
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-24098872009-09-10 Cervical cancer screening programmes and policies in 18 European countries Anttila, A Ronco, G Clifford, G Bray, F Hakama, M Arbyn, M Weiderpass, E Br J Cancer Epidemiology A questionnaire survey was conducted by the Epidemiology Working Group of the European Cervical Cancer Screening Network, and the International Agency for Research on Cancer, IARC, between August and December 2003 in 35 centres in 20 European countries with reliable cervical cancer incidence and/or mortality data in databanks held at IARC and WHO. The questionnaire was completed by 28 centres from 20 countries. The final tables included information on 25 centres from 18 countries. Six countries had started screening in the 1960s, whereas 10 countries or regions had started at least a pilot programme by 2003. There were six invitational and nine partially invitational programmes, the rest employing opportunistic screening only. Recommended lifetime number of smears varied from seven to more than 50. Coverage of smear test within the recommended screening interval (usually 3 or 5 years) was above 80% in three countries. Screening registration took place in 13 programmes. Eight programmes reported the rates of screen-detected cervical cancers and precursor lesions. There was wide variation in the CIN3 detection rates. International guidelines and quality assurance protocols are useful for monitoring and evaluating screening programmes systematically. Our survey indicated that the recommendations as currently given are met in only few European countries. Health authorities need to consider stronger measures and incentives than those laid out in the current set of recommendations. Nature Publishing Group 2004-08-31 2004-07-27 /pmc/articles/PMC2409887/ /pubmed/15280916 http://dx.doi.org/10.1038/sj.bjc.6602069 Text en Copyright © 2004 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Epidemiology
Anttila, A
Ronco, G
Clifford, G
Bray, F
Hakama, M
Arbyn, M
Weiderpass, E
Cervical cancer screening programmes and policies in 18 European countries
title Cervical cancer screening programmes and policies in 18 European countries
title_full Cervical cancer screening programmes and policies in 18 European countries
title_fullStr Cervical cancer screening programmes and policies in 18 European countries
title_full_unstemmed Cervical cancer screening programmes and policies in 18 European countries
title_short Cervical cancer screening programmes and policies in 18 European countries
title_sort cervical cancer screening programmes and policies in 18 european countries
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2409887/
https://www.ncbi.nlm.nih.gov/pubmed/15280916
http://dx.doi.org/10.1038/sj.bjc.6602069
work_keys_str_mv AT anttilaa cervicalcancerscreeningprogrammesandpoliciesin18europeancountries
AT roncog cervicalcancerscreeningprogrammesandpoliciesin18europeancountries
AT cliffordg cervicalcancerscreeningprogrammesandpoliciesin18europeancountries
AT brayf cervicalcancerscreeningprogrammesandpoliciesin18europeancountries
AT hakamam cervicalcancerscreeningprogrammesandpoliciesin18europeancountries
AT arbynm cervicalcancerscreeningprogrammesandpoliciesin18europeancountries
AT weiderpasse cervicalcancerscreeningprogrammesandpoliciesin18europeancountries